» Articles » PMID: 36433591

Comparison of Oxytocin Vs. Carbetocin Uterotonic Activity After Caesarean Delivery Assessed by Electrohysterography: A Randomised Trial

Overview
Journal Sensors (Basel)
Publisher MDPI
Specialty Biotechnology
Date 2022 Nov 26
PMID 36433591
Authors
Affiliations
Soon will be listed here.
Abstract

Electrohysterography has been used for monitoring uterine contractility in pregnancy and labour. Effective uterine contractility is crucial for preventing postpartum haemorrhage. The objective of our study was to compare postpartum electrohysterograms in women receiving oxytocin vs. carbetocin for postpartum haemorrhage prevention after caesarean delivery. The trial is registered at ClinicalTrials.gov with the identifier NCT04201665. We included 64 healthy women with uncomplicated singleton pregnancies at term scheduled for caesarean section after one previous caesarean section. After surgery, a 15 min electrohysterogram was obtained after which women were randomised to receive either five IU of oxytocin intravenously or 100 μg of carbetocin intramuscularly. A 30 min electrohysterogram was performed two hours after drug application. Changes in power density spectrum peak frequency of electrohysterogram pseudo-bursts were analysed. A significant reduction in power density spectrum peak frequency in the first two hours was observed after carbetocin but not after oxytocin (median = 0.07 (interquartile range (IQR): 0.87 Hz) compared to median = -0.63 (IQR: 0.20) Hz; = 0.004). Electrohysterography can be used for objective comparison of uterotonic effects. We found significantly higher power density spectrum peak frequency two hours after oxytocin compared to carbetocin.

References
1.
Buhimschi C, Garfield R . Uterine contractility as assessed by abdominal surface recording of electromyographic activity in rats during pregnancy. Am J Obstet Gynecol. 1996; 174(2):744-53. DOI: 10.1016/s0002-9378(96)70459-3. View

2.
Cole N, Carvalho J, Erik-Soussi M, Ramachandran N, Balki M . In Vitro Comparative Effect of Carbetocin and Oxytocin in Pregnant Human Myometrium with and without Oxytocin Pretreatment. Anesthesiology. 2015; 124(2):378-86. DOI: 10.1097/ALN.0000000000000940. View

3.
Gallos I, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price M . Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018; 12:CD011689. PMC: 6388086. DOI: 10.1002/14651858.CD011689.pub3. View

4.
Wallach E, Vu K . Myomata uteri and infertility. Obstet Gynecol Clin North Am. 1995; 22(4):791-9. View

5.
. Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No. 52. BJOG. 2016; 124(5):e106-e149. DOI: 10.1111/1471-0528.14178. View